(Credit-Canva)
A lot of our body’s functions depend on when we are defecating and how well our bowel movements are taking place. People have different pooping habits, with some people having a nightly routine and others enjoying a morning bathroom run. But is it normal for one to run to the bathroom after every meal? Not only is it inconvenient but it could be a sign of something going wrong with your body. Have you ever enjoyed a meal and immediately needed to use the restroom?
If so, you might be worried that something is wrong with you. But you don’t need to stress about this! It is actually quite common and doesn't necessarily indicate a health problem.
This phenomenon is called the gastrocolic reflex. When food enters your stomach, it triggers a series of signals in your digestive system. Your stomach stretches to accommodate the food, and sends signals to your brain through the vagus nerve. The brain then communicates with your large intestine, telling it to make room for the new food by moving its current contents along. In other words, you're not pooping out what you just ate, but what has been in your digestive system for a day or two.
Credit: iStock
According to the World Health Organization (WHO), tobacco use kills over 8 million people globally each year, including non-smokers exposed to second-hand smoke.
India continues to face a massive burden of tobacco addiction. Cigarettes, bidis, gutka, pan masala and khaini continue to affect millions, including young adults. This year’s WHO theme- “Unmasking the Appeal: Countering Nicotine and Tobacco Addiction” focuses on how flavoured products, attractive packaging and social media marketing are making nicotine products appealing to the younger generation.
Tobacco damages nearly every organ in the body. It is strongly linked to cancers of the mouth, throat, voice box, lungs, food pipe and bladder. In India, oral cancer remains one of the commonest cancers, largely driven by smokeless tobacco use. Tobacco also increases the risk of heart attacks, strokes, chronic lung disease, infertility and poor immunity.
Many people mistakenly believe that e-cigarettes and vaping are “safe alternatives.” However, e-cigarettes still contain addictive nicotine and harmful chemicals that can damage the lungs and cardiovascular system. They may also act as a gateway to conventional tobacco use among teenagers and young adults. Recognising these risks, India banned the production, sale and advertisement of e-cigarettes under the Prohibition of Electronic Cigarettes Act, 2019.
The encouraging fact is that quitting works at any age. Within weeks of stopping tobacco, blood pressure and lung function begin to improve, while long-term risks of cancer and heart disease reduce significantly.
* Fix a quit date and inform family and friends.
* Identify triggers such as stress, tea, alcohol or social gatherings.
* Avoid keeping tobacco products nearby.
* Stay physically active and hydrated.
* Seek professional counselling if cravings are severe.
* Nicotine replacement therapy or prescribed medications may help selected individuals.
* Remember that relapses can happen and restarting the quit journey is still progress.
World No Tobacco Day is not just about awareness but is a call to action. Choosing to quit today may be the single most important decision for a healthier and longer life.
(Dr Akshat Malik, Senior Consultant, Head & Neck Oncology, Apollo Hospital, Delhi)
Credits: Canva
According to the Indian Council of Medical Research - National Cancer Registry Programme (ICMR-NCRP), India reports about 220,000 new cases every year, and the common treatment procedure for this disease is chemotherapy, which comes with profound fatigue, hair loss, nausea, compromised immunity, and nerve damage.
The University College London led the Optima trial, which studied over 4000 patients with the disease in different parts of the world, and a low score on the genomic test could be mediated with only hormone therapy.
The trial’s chief investigator and a professor of breast oncology at UCL, Professor Rob Stein, explains that the study used tumour biology to guide decisions instead of relying on traditional clinical procedures.
The research had 4,429 women participants above the age of 40 years with hormone-positive breast cancer. These patients were then divided into two groups based on the genomic test results by the researchers, and one group with a higher risk was given chemotherapy along with hormone therapy, while the others were only treated with hormone therapy.
Breast cancer refers to the uncontrolled growth of the cells that are found along the inner lining of breast tissue. This out-of-control growth of cells leads to the formation of tumours. The tumour can be “invasive”, meaning that it spreads to the nearby tissues outside the breast, or “in situ”, where the tumour does not spread outside the breast region.
Usually, the “in situ” type of tumour is non-cancerous and non-life-threatening. However, in the case of invasive tumours, the cancerous cell mass can spread to the lymph nodes and further metastasise, that is, spread to other body parts. About 80% times the breast cancer cases are invasive. Hence, upon noticing symptoms like lumps, changes in breast shape, or abnormal nipple discharge, you must promptly consult a doctor.
While both men and women can develop it, in 99% of cases of breast cancer, women are seen to be affected by it. Only 0.5 to 1% of men are affected due to this condition. Furthermore, the condition is mostly prevalent in women aged 50 or older.
Credit: iStocks
After the advent of Ozempic-like drugs, the treatment of obesity has completely changed. Millions of people throughout the world use the medication either for obesity or diabetes. Although there were always concerns among medical professionals that the medication not only reduces fat but also lean muscle, which in turn leads to health loss, as muscle is very important to long-term health.
Now, a new study presented at the European Atherosclerosis Society (EAS) Congress 2026 claims that this vital minus point of the drug, causing lean fat loss, can be mended by pairing it with exercise. The study suggests that combining the drug with exercise can lead to better fat loss, while the muscle will also stay protected. Though the study was done on animals, further research on humans is required.
The researchers studied mice with obesity, insulin resistance, fatty liver disease, and atherosclerosis. The animals were divided into groups and given semaglutide. After 14 weeks, it was found that the drug alone reduced fat by 31 percent but also caused muscle loss, while when the medication was given with exercise, it caused fat loss by 45 percent, and lean mass loss was minimal.
The first thing to remember here is that Ozempic is a brand-name medicine that contains semaglutide as its active ingredient. Semglutide is the synthetic version of GLP-1, a natural hormone produced in the intestines that regulates blood sugar, appetite, and digestion. Now, every time you eat, your body produces various hormones, including GLP-1. These are called post-nutrition hormones and help you absorb the energy you just consumed.
GLP-1 travels to your pancreas, prompting it to produce insulin. It also travels to the hypothalamus in your brain, which gives you the feeling of being full or satiated. Ozempic imitates this hormone, thereby silencing the food chatter in the brain. Interestingly, for some people this food chatter is really quiet ( people with low appetite), and for others it is an outburst (people who generally binge eat). So with Ozempic, silencing this self-talk in the brain, people tend to lose their appetite and eventually weight.
However, it is important to note that losing weight includes not just fat but muscle as well. Losing too much muscle can lead to reduced strength and a shorter life span. Notably, records show that most people who start taking them stop them at 12 weeks; therefore, it is important for some but not for others.
© 2024 Bennett, Coleman & Company Limited